Showing results (231-240 of 781) with videos related to
Sort By:
Pageof 79
Microsurgery|February 21, 2008
Penile replantation, complication management, and technique refinementErh-Kang Chou, Yu-Tzu Tai, Chao-I Wu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2016
Dual NAMPT and BTK Targeting Leads to Synergistic Killing of Waldenström Macroglobulinemia Cells Regardless of MYD88 and CXCR4 Somatic Mutation StatusMichele Cea, Antonia Cagnetta, Chirag Acharya, et al.Blood|December 18, 2015
Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cellsMichele Cea, Antonia Cagnetta, Sophia Adamia, et al.Blood|September 20, 2014
Differential and limited expression of mutant alleles in multiple myelomaNaim U Rashid, Adam S Sperling, Niccolo Bolli, et al.Nature Reviews. Clinical Oncology|January 10, 2018
The bone-marrow niche in MDS and MGUS: implications for AML and MMIrene M Ghobrial, Alexandre Detappe, Kenneth C Anderson, et al.Cell Cycle (Georgetown, Tex.)|October 7, 2004
Mcl-1 regulation and its role in multiple myelomaSteven Le Gouill, Klaus Podar, Jean-Luc Harousseau, et al.British Journal of Haematology|May 12, 2018
Investigational agents in immunotherapy: a new horizon for the treatment of multiple myelomaCindy Varga, Jacob P Laubach, Kenneth C Anderson, et al.Seminars in Oncology|April 30, 2003
Proteomic analyses in Waldenstrom's macroglobulinemia and other plasma cell dyscrasiasConstantine S Mitsiades, Nicholas Mitsiades, Steven P Treon, et al.Best Practice & Research. Clinical Haematology|July 20, 2005
Novel biological therapies for the treatment of multiple myelomaPaul G Richardson, Constantine S Mitsiades, Teru Hideshima, et al.Blood|April 20, 2004
Advances in biology of multiple myeloma: clinical applicationsTeru Hideshima, P Leif Bergsagel, W Michael Kuehl, et al.Pageof 79